Blueprint Medicines Corp buy BiotechBee
Start price
07.09.22
/
60%
€74.46
Target price
31.12.24
€100.00
Performance (%)
-29.49%
End price
05.05.23
€52.50
Summary
This prediction ended on 05.05.23 with a price of €52.50. The price of Blueprint Medicines Corp has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.49%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
According to BiotechBee what are the pros and cons of Blueprint Medicines Corp for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Blueprint Medicines Corp diskutieren
Buy mit Kursziel 100,0